Project Scope Across industry, there are a wide variety of quality control (QC) checks for SEND datasets. This is currently done without commonly acknowledged scope and intensity, based on the companies own approaches. For more confidentiality of the quality of SEND dataset across different stakeholders this group targets to:
|
Project Leads | |||
---|---|---|---|
Jesse Anderson | jesse.anderson@fda.hhs.gov | (FDA) | |
Michael Rosentreter (Bayer) |
Key Milestones
Katie Warren (PHUSE Project Assistant) | katie@phuse.global |
|
---|
Project Members
Alejandro Mankin
Arianne Motter
Brett Coupland
Astrazeneca
Cassandra O’Malley
Diane Boram
Eduardo Mundo
Erin Tibbs-Slone
Gitte Ullmann
Haley Wulff
Isaac Mativo
Jamie Gilliam
Janessa Piers
Jennifer Feldmann
Karen Porter
Karuna Polavarapu
Kathryn Brown
Kurien Abraham
Project Members
Laura Kaufman
Lindsy Eickhoff
Mandie Rhodes
Matt Bendekovits
Merck
Matt Hayes
Patty Brundage
Peyton Myers
Phil Drew
Rick Thompson
Senthil Palani
Sonja Geuens
Stefano Gaudio
Steve Polly
Susie Antvorskov
Q3/4 2022 |
---|
Project Closed
|
Objectives & Deliverables | Timelines |
---|---|
Produce list of standard explanations for validation issues | Q2 2022 |
White Paper: Recommendations for SEND Dataset QC Best Practices | Q2 2022 |
Planned poster for PHUSE CSS 2022 | Q3 2022 |
Published Deliverables | |
---|---|
Recommendations for SEND Dataset QC Best Practices | 21 June 2022 |